Senti Biosciences Holdings (SNTI) EBIT Margin Growth (3y) (2026)
Powered by 
Analysis
Senti Biosciences Holdings (SNTI) EBIT Margin Growth (3y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | -101,581.00 |
| 3 | Iovance Biotherapeutics | 3.73 Bn | 3.44 Bn | 55.72 Mn | 4.62 Mn |
| 4 | Legend Biotech | 3.62 Bn | 2.66 Bn | 251.50 Mn | -20,903.00 |
| 5 | uniQure | 2.99 Bn | 2.99 Bn | 5.49 Mn | 179,305.00 |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | -2.53 Mn |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 123,643.00 |
| 8 | Sarepta Therapeutics | 2.25 Bn | 1.46 Bn | 251.87 Mn | 5,442.00 |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | 1,354.00 |
| 10 | Senti Biosciences Holdings | 9.34 Mn | 9.34 Mn | - | -8.36 Mn |